๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Radioimmunotherapy with ibritumomab tiuxetan beneficial in NHL


Book ID
120862510
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2002
Weight
138 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Yttrium-90 ibritumomab tiuxetan radioimm
โœ Apostolia-Maria Tsimberidou; James L. Murray; Susan O'Brien; William G. Wierda; ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 82 KB

## Abstract ## BACKGROUND ^90^Y ibritumomab tiuxetan is a radioimmunotherapeutic construct that is reported to be an effective treatment for patients with lymphoma. The aim of the current analysis was to evaluate retrospectively the efficacy and safety of ^90^Y ibritumomab tiuxetan in patients wit